Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Arena Pharmaceuticals Inc. (ARNA)

62.07   0.59 (0.96%) 07-15 16:00
Open: 61.87 Pre. Close: 61.48
High: 62.44 Low: 61.52
Volume: 268,017 Market Cap: 3077M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 62.517 - 62.749 62.749 - 62.935
Low: 60.888 - 61.183 61.183 - 61.42
Close: 61.629 - 62.082 62.082 - 62.447

Technical analysis

as of: 2019-07-15 4:40:19 PM
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 73.16     One year: 85.45
Support: Support1: 57.75    Support2: 54.72
Resistance: Resistance1: 62.64    Resistance2: 73.16
Pivot: 59.68
Moving Average: MA(5): 61.15     MA(20): 59.11
MA(100): 51.29     MA(250): 44.99
MACD: MACD(12,26): 1.75     Signal(9): 1.68
Stochastic oscillator: %K(14,3): 83.14     %D(3): 78.04
RSI: RSI(14): 65.27
52-week: High: 62.64  Low: 31.97  Change(%): 41.0
Average Vol(K): 3-Month: 55628  10-Days: 45457

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
ARNA has closed below upper band by 21.2%. Bollinger Bands are 25% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 04 Jul 2019 08:34:22 Z
Validea Joel Greenblatt Strategy Daily Upgrade Report - 7/4/2019

Wed, 03 Jul 2019 13:35:18 Z
ARNA Crosses Above Average Analyst Target

Tue, 18 Jun 2019 16:40:17 Z
Arena Initiates Dosing in Pivotal Colitis Study on Etrasimod

Sun, 16 Jun 2019 22:27:51 Z
Validea's Top Five Healthcare Stocks Based On David Dreman - 6/16/2019

Fri, 07 Jun 2019 16:00:39 Z
Why Is Arena Pharmaceuticals (ARNA) Up 9.1% Since Last Earnings Report?

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 49.57
Shares Float (M) 46.23
% Held by Insiders 0.16
% Held by Institutions 85.23
Shares Short (K) 3850
Shares Short P. Month (K)

Stock Financials

EPS 12.490
EPS Est. Current Year -2.940
EPS Est. Next Year -2.730
EPS Est. Next Quarter -0.660
Forward EPS -3.211
Book Value (p.s.) 25.090
PEG Ratio -0.35
Profit Margin 76.19
Operating Margin 76.51
Return on Assets (ttm) 38.8
Return on Equity (ttm) 68.1
Qtrly Rev. Growth 45544.3
Gross Profit (p.s.) -1.958
Sales Per Share
EBITDA (p.s.) 12.686
Qtrly Earnings Growth
Operating Cash Flow (M) 635.22
Levered Free Cash Flow (M) 406.34

Stock Valuations

P/E 4.97
P/E Growth Ratio 0.01
P/BV 2.47
P/S 186022368.00
P/CF 4.84

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2017-06-19
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.